Literature DB >> 2630409

Microbial transformation of semisynthetic derivatives of daunomycinone modified in ring A.

V Prikrylova1, J Jizba, M Blumauerova, J Huk, P Sedmera.   

Abstract

Semisynthetic derivatives of daunomycinone with 7,9-isopropylacetal, 7-O-methyl, 7-O-(4-penten-2-yl), and 7-O-(2-hydroxyethyl) substituents were converted by Streptomyces peucetius var. caesius (an adriamycin-blocked mutant) into 7-deoxy-13-dihydrodaunomycinone, while daunomycinone was transformed into 13-dihydrodaunomycinone (predominantly) and 7-deoxy-13-dihydrodaunomycinone. S. coeruleorubidus mutants 24-74 (accumulating aclavinone derivatives instead of daunomycin and related compounds) and 96-85 (producing no anthracycline substances), and S. aureofaciens B-96 (a tetracycline-blocked mutant) transformed the above substrates into the corresponding 13-dihydro derivatives, with the exception of 7,9-isopropylacetal daunomycinone which remained intact. 7-O-Propyn-1-yl daunomycinone was not transformed by any of the strains used under the conditions.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2630409     DOI: 10.1007/bf02820754

Source DB:  PubMed          Journal:  Folia Microbiol (Praha)        ISSN: 0015-5632            Impact factor:   2.099


  10 in total

1.  Microbial conversion of anthracycline antibiotics.

Authors:  P F Wiley; V P Marshall
Journal:  J Antibiot (Tokyo)       Date:  1975-10       Impact factor: 2.649

2.  Bacterial metabolism of daunomycin.

Authors:  V P Marshall; E A Reisender; P F Wiley
Journal:  J Antibiot (Tokyo)       Date:  1976-09       Impact factor: 2.649

3.  Regulation of biosynthesis of secondary metabolites. IX. The biosynthetic activity of blocked mutants of Streptomyces aureofaciens.

Authors:  M Blumauerová; M Mracek; J Vondrácková; M Podojil; Z Hostálek; Z Vanĕk
Journal:  Folia Microbiol (Praha)       Date:  1969       Impact factor: 2.099

4.  Microbial transformation of daunomycinone by Streptomyces aureofaciens B-96.

Authors:  J Karnetová; J Matĕjů; P Sedmera; J Vokoun; Z Vanĕk
Journal:  J Antibiot (Tokyo)       Date:  1976-11       Impact factor: 2.649

Review 5.  Antitumor anthracyclines: recent developments.

Authors:  F Arcamone
Journal:  Med Res Rev       Date:  1984 Apr-Jun       Impact factor: 12.944

6.  Reductive cleavage of anthracycline glycosides by microsomal NADPH-cytochrome C reductase.

Authors:  T Oki; T Komiyama; H Tone; T Inui; T Takeuchi; H Umezawa
Journal:  J Antibiot (Tokyo)       Date:  1977-07       Impact factor: 2.649

7.  Microbial conversion of daunomycin, carminomycin I and feudomycin A to adriamycin.

Authors:  T Oki; Y Takatsuki; H Tobe; A Yoshimoto; T Takeuchi; H Umezawa
Journal:  J Antibiot (Tokyo)       Date:  1981-09       Impact factor: 2.649

8.  Biotransformations of anthracyclinones in Streptomyces coeruleorubidus and Streptomyces galilaeus.

Authors:  M Blumauerová; E Královcová; J Matĕjů; J Jizba; Z Vanĕk
Journal:  Folia Microbiol (Praha)       Date:  1979       Impact factor: 2.099

9.  Microbial transformations of natural antitumor agents. 13. Conversions of 13-blocked anthracyclinones.

Authors:  G S Wu; A Gard; J P Rosazza
Journal:  J Antibiot (Tokyo)       Date:  1980-07       Impact factor: 2.649

10.  Mutants of Streptomyces coeruleorubidus impaired in the biosynthesis of daunomycinone glycosides and related metabolites.

Authors:  M Blumauerová; K Stajner; V Pokorný; Z Hostálek; Z Vanĕk
Journal:  Folia Microbiol (Praha)       Date:  1978       Impact factor: 2.099

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.